NCT06336603View on ClinicalTrials.gov

A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

October 29, 2024

Study Completion Date

October 29, 2024

Conditions

Acne Vulgaris

Interventions

DRUG

Winlevi (clascoterone) 1% & Adapalene 0.3% gel

Participants will use Winlevi (clascoterone) 1% twice daily (BID) and Adapalene 0.3% once daily (QD)

Trial Locations (1)

40217

Skin Sciences, PLLC, Louisville

All Listed Sponsors

lead

Sun Pharmaceutical Industries Limited

INDUSTRY

NCT06336603 - A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of Acne | Biotech Hunter | Biotech Hunter